Free Trial
→ When This Happens, You Don’t Wait. You Act. (From Crypto Swap Profits) (Ad)
OTCMKTS:MCUJF

Medicure 7/28/2023 Earnings Report

Medicure logo
$0.83 -0.03 (-3.84%)
As of 06/13/2025 01:30 PM Eastern
ProfileEarnings History

Medicure EPS Results

Actual EPS
$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Medicure Revenue Results

Actual Revenue
$4.46 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Medicure Announcement Details

Quarter
Date
7/28/2023
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Medicure's next earnings date is estimated for Tuesday, August 12, 2025, based on past reporting schedules.

Conference Call Resources

Medicure Earnings Headlines

Medicure reports stable intangible assets in Q1 filing
May 23, 2025 | investing.com
Medicure Inc. (MCUJF) Q4 2024 Earnings Call Transcript
April 30, 2025 | seekingalpha.com
[Wanted] 250 intrepid souls
He Called this 106X Opportunity Before Reddit… and Before Elon Musk Before GameStop rocketed up to 10,633, Jonathan Rose saw something strange: A sudden surge in options volume — thousands of contracts flooding in. The money hit deep inside the CBOE before Reddit posts created the short squeeze and before Elon's tweet sent GameStop flying. Jonathan calls it the "Big-Money Tell," and it's flagged dozens of big trade opportunities including: 462.5% in C3.ai, 245.13% in Criteo, and 39.46% in Roku. And these are just some of the gains the "tell" has identified. Even better: He says the next big set-up could be forming right now. And there's still time for you to get in before it kicks off as soon as seven days from now.
June 16, 2025 | Masters in Trading (Ad)
Medicure Inc. Reports 2024 Financial Results with Increased Revenue but Net Loss
April 25, 2025 | tipranks.com
Medicure Expands U.S. Pharmacy Business with West Olympia Acquisition
April 11, 2025 | tipranks.com
Medicure Completes Strategic Acquisition of Gateway Medical Pharmacy
March 11, 2025 | tipranks.com
See More Medicure Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Medicure? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Medicure and other key companies, straight to your email.

About Medicure

Medicure (OTCMKTS:MCUJF), a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company offers Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.

View Medicure Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles